[1] 王一帆, 于海荣, 吕博杰. 甲状腺功能亢进症的治疗研究进展[J]. 承德医学院学报, 2019, 36(4):340-343. [2] McGahan JP. Hepatic ablation using bipolar radiofrequency electrocautery[J]. Acad Radiol, 1996, 3(5) : 418-422. [3] Kim YS,Rhim H,Tae K,et al.Radiofrequency ablation of benign cold thyroid nodules:initial clinical experience[J]. Thyroid, 2006, 16(4):361-367. [4] Cui D,Ding M,Tang X, et al.Efficacy and safety of a combination of hydrodissection and radiofrequency ablation therapy for benign thyroid nodules larger than 2cm: A retrospective study[J]. J Cancer Res Ther,2019,15(2):386-393. [5] 中华医学会内分泌学分会.标准·方案·指南——成人甲状腺功能减退症的诊治指南推荐要点[J].中国全科医学, 2017, 5(13): 1630. [6] 韦雪云,张雄文,许海燕.甲亢围手术期的护理及评估[J].外科研究与新技术,2018,7(3):149-152. [7] 肇博,左长京,潘文舟,等.131碘与抗甲状腺药物治疗甲亢的临床疗效比较[J].现代生物医学进展,2016,16(15): 2882-2884. [8] Wang R,Jian T,Zhang G,et al.Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment[J]. Medicine, 2017, 96(5): e6035. [9] 徐栋. 甲状腺热消融治疗规范与共识解读[J].中华医学超声杂志(电子版), 2020, 17(1):96-96. [10] 王龙琦,陈坚,刘绪舜.微波消融术治疗2例原发性甲状旁腺功能亢进[J].中国微创外科杂志,2016,16(6): 541-543. |